TB500 Spray contains a research-grade synthetic peptide fragment corresponding to a region of thymosin beta-4, formulated in a liquid spray format for controlled laboratory applications. This compound is widely used in preclinical investigations focusing on cellular dynamics, cytoskeletal regulation, and tissue-level responses. For research use only. Not for human use.
All information below is derived from publicly available scientific data, including PubChem.
TB500 refers to a synthetic peptide consisting of part of the sequence of thymosin beta-4, an actin-binding protein classified as a naturally occurring 43-amino-acid peptide. According to PubChem, thymosin beta-4 is associated with actin-sequestering activity and cytoskeletal organization within eukaryotic cells [1]. TB500, as a truncated analog, is widely used in controlled research environments for studying mechanisms related to cellular structure and motility.
Below are the primary scientific fields where TB500 continues to be investigated.
Thymosin beta-4 is recognized for its high affinity for monomeric G-actin, influencing actin polymerization dynamics [1]. Because TB500 is derived from this parent peptide, researchers frequently use it to investigate:
In vitro investigations continue to examine how fragments of thymosin beta-4 influence cytoskeletal architecture and whether specific peptide segments differentially modulate actin-binding properties [1].
In preclinical models, thymosin beta-4 has been studied for its role in cell proliferation, cell migration, and extracellular matrix remodeling [1]. TB500 is therefore applied in laboratory studies assessing:
These studies do not evaluate clinical outcomes; instead, they focus on understanding biochemical pathways and cellular behaviors relevant to tissue repair models.
Thymosin beta-4 has been referenced in immunological research exploring cytokine modulation and inflammatory cascades [1]. TB500 continues to be explored for:
These investigations aim to clarify peptide-mediated pathways rather than evaluate therapeutic potential.
TB500 is also used in structural biology investigations to explore specific peptide regions responsible for actin regulation. PubChem identifies thymosin beta-4’s sequence, structural characteristics, and function, supporting ongoing research into:
These studies support fundamental understanding rather than applied therapeutic research.
This product is meant only for research use. It is made for lab testing and in vitro experiments (outside a living body), not for use in people or animals. All information on this website is for learning purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. It should only be used by trained professionals in a proper lab setting. This product is not a medicine, food, or cosmetic, and must not be sold or used as one.
